IDEAS home Printed from https://ideas.repec.org/r/eee/respol/v30y2001i3p485-508.html
   My bibliography  Save this item

Technological change and network dynamics: Lessons from the pharmaceutical industry

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Malerba, Franco, 2007. "Innovation and the dynamics and evolution of industries: Progress and challenges," International Journal of Industrial Organization, Elsevier, vol. 25(4), pages 675-699, August.
  2. Joel A. C. Baum & Robin Cowan & Nicolas Jonard, 2010. "Network-Independent Partner Selection and the Evolution of Innovation Networks," Management Science, INFORMS, vol. 56(11), pages 2094-2110, November.
  3. Lionel Nesta & Vincent Mangematin, 2002. "Industry Life Cycle, Knowledge Generation and Technological Networks," Grenoble Ecole de Management (Post-Print) hal-03398092, HAL.
  4. Philip Cooke, 2004. "Life Sciences Clusters and Regional Science Policy," Urban Studies, Urban Studies Journal Limited, vol. 41(5-6), pages 1113-1131, May.
  5. Jürgens, Ulrich & Sablowski, Thomas, 2008. "Sektorale Innovationsprozesse und die Diskussion über deutsche Innovationsschwächen," Study / edition der Hans-Böckler-Stiftung, Hans-Böckler-Stiftung, Düsseldorf, volume 127, number 204, June.
  6. Annika Rickne, 2006. "Connectivity and Performance of Science-based Firms," Small Business Economics, Springer, vol. 26(4), pages 393-407, May.
  7. Farasat A. S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2021. "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Small Business Economics, Springer, vol. 57(1), pages 603-634, June.
  8. Mauro Napoletano & Stefano Battiston & Michael König & Frank Schweitzer, 2008. "The efficiency and evolution of R&D Networks," Sciences Po publications 2008-31, Sciences Po.
  9. Jason Owen-Smith & Massimo Riccaboni & Fabio Pammolli & Walter W. Powell, 2002. "A Comparison of U.S. and European University-Industry Relations in the Life Sciences," Management Science, INFORMS, vol. 48(1), pages 24-43, January.
  10. Pammolli, Fabio & Riccaboni, Massimo, 2002. "Technological Regimes and the Growth of Networks: An Empirical Analysis," Small Business Economics, Springer, vol. 19(3), pages 205-215, November.
  11. Dosi Giovanni & Gambardella Alfonso & Grazzi Marco & Orsenigo Luigi, 2008. "Technological Revolutions and the Evolution of Industrial Structures: Assessing the Impact of New Technologies upon the Size and Boundaries of Firms," Capitalism and Society, De Gruyter, vol. 3(1), pages 1-49, June.
  12. Kolympiris, Christos & Kalaitzandonakes, Nicholas & Miller, Douglas, 2014. "Public funds and local biotechnology firm creation," Research Policy, Elsevier, vol. 43(1), pages 121-137.
  13. Havas, Attila, 2010. "Diversity in firms’ innovation strategies and activities: Main findings of interviews and implications in the context of the Hungarian national," MPRA Paper 55852, University Library of Munich, Germany.
  14. Herrmann, Andrea M., 2008. "On the discrepancies between macro and micro level identification of competitive strategies," MPIfG Discussion Paper 08/6, Max Planck Institute for the Study of Societies.
  15. Giulio Cainelli & Sandro Montresor & Giuseppe Vittucci Marzetti, 2013. "Production and financial linkages in inter-firm networks: structural variety, risk-sharing and resilience," Economic Complexity and Evolution, in: Andreas Pyka & Esben Sloth Andersen (ed.), Long Term Economic Development, edition 127, pages 113-136, Springer.
  16. Martin Backfisch, 2017. "Have Pharmaceutical R&D Project Success Rates Decreased? A Critical Review and New Empirical Results," MAGKS Papers on Economics 201746, Philipps-Universität Marburg, Faculty of Business Administration and Economics, Department of Economics (Volkswirtschaftliche Abteilung).
  17. Milanov, Hana & Fernhaber, Stephanie A., 2009. "The impact of early imprinting on the evolution of new venture networks," Journal of Business Venturing, Elsevier, vol. 24(1), pages 46-61, January.
  18. Andreas Pyka & Paolo Saviotti, 2001. "Innovation Networks in the Biotechnology-Based Sectors," Discussion Paper Series 205, Universitaet Augsburg, Institute for Economics.
  19. Olie, R.L. & Glunk, U. & Heijltjes, M.G., 2003. "Continuity and renewal at the top: performance effects of the level, extent, type and frequency of top management team changes," Research Memorandum 049, Maastricht University, Maastricht Research School of Economics of Technology and Organization (METEOR).
  20. Dantas, Eva & Bell, Martin, 2009. "Latecomer firms and the emergence and development of knowledge networks: The case of Petrobras in Brazil," Research Policy, Elsevier, vol. 38(5), pages 829-844, June.
  21. Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2005. "The knowledge bases of the world's largest pharmaceutical groups: what do patent citations to non-patent literature reveal?," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 14(5), pages 395-415.
  22. repec:hal:spmain:info:hdl:2441/9935 is not listed on IDEAS
  23. Maureen McKelvey & Bastian Rake, 2012. "Research Network Position and Innovative Performance: Evidence from the Pharmaceutical Industry," Jena Economics Research Papers 2012-021, Friedrich-Schiller-University Jena.
  24. Zhang, Jing & Baden-Fuller, Charles & Mangematin, Vincent, 2007. "Technological knowledge base, R&D organization structure and alliance formation: Evidence from the biopharmaceutical industry," Research Policy, Elsevier, vol. 36(4), pages 515-528, May.
  25. Andrea Bonaccorsi & R. Cambini & Paola Giuri & R. Riccardi, 2001. "Non ergodic properties of the dynamics of industry concentration," LEM Papers Series 2001/12, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  26. Stefano Brusoni & Lorenzo Cassi & Simge Tuna, 2021. "Knowledge integration between technical change and strategy making," Journal of Evolutionary Economics, Springer, vol. 31(5), pages 1521-1552, November.
  27. Kelchtermans, Stijn & Leten, Bart & Rabijns, Maarten & Riccaboni, Massimo, 2022. "Do licensors learn from out-licensing? Empirical evidence from the pharmaceutical industry," Technovation, Elsevier, vol. 112(C).
  28. Tatiana Plotnikova & Bastian Rake, 2014. "Collaboration in pharmaceutical research: exploration of country-level determinants," Scientometrics, Springer;Akadémiai Kiadó, vol. 98(2), pages 1173-1202, February.
  29. Flori, Andrea & Pammolli, Fabio & Spelta, Alessandro, 2021. "Commodity prices co-movements and financial stability: A multidimensional visibility nexus with climate conditions," Journal of Financial Stability, Elsevier, vol. 54(C).
  30. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Maria Alessandra Rossi, 2009. "Patent disclosure and R&D competition in pharmaceuticals," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 18(5), pages 467-486.
  31. Ron Boschma & Dirk Fornahl, 2011. "Cluster Evolution and a Roadmap for Future Research," Regional Studies, Taylor & Francis Journals, vol. 45(10), pages 1295-1298, November.
  32. Bonaccorsi, Andrea & Giuri, Paola, 2001. "Network structure and industrial dynamics. The long-term evolution of the aircraft-engine industry," Structural Change and Economic Dynamics, Elsevier, vol. 12(2), pages 201-233, July.
  33. Boutillier, Sophie & Laperche, Blandine & Lebert, Didier & Elouaer-Mrizak, Sana, 2023. "A systemic analysis of the technological trajectory at company level based on patent data: The case of Sanofi's vaccine technology," Technovation, Elsevier, vol. 124(C).
  34. Ozman, Müge, 2003. "Self-Organizing Inter-Firm Networks," Research Memorandum 022, Maastricht University, Maastricht Economic Research Institute on Innovation and Technology (MERIT).
  35. Franco Malerba, 2006. "Innovation, Industrial Dynamics and Industry Evolution: Progress and the Research Agendas," Revue de l'OFCE, Presses de Sciences-Po, vol. 97(5), pages 21-46.
  36. M. Nicotra & M. Romano & M. Giudice, 2014. "The Evolution Dynamic of a Cluster Knowledge Network: The Role of Firms’ Absorptive Capacity," Journal of the Knowledge Economy, Springer;Portland International Center for Management of Engineering and Technology (PICMET), vol. 5(2), pages 240-264, June.
  37. Jackie Krafft & Francesco Quatraro & Pier Saviotti, 2014. "Knowledge characteristics and the dynamics of technological alliances in pharmaceuticals: empirical evidence from Europe, US and Japan," Journal of Evolutionary Economics, Springer, vol. 24(3), pages 587-622, July.
  38. Luo, Xiaowei Rose & Koput, Kenneth W. & Powell, Walter W., 2009. "Intellectual capital or signal? The effects of scientists on alliance formation in knowledge-intensive industries," Research Policy, Elsevier, vol. 38(8), pages 1313-1325, October.
  39. Corine Genet & Khalid Errabi & Caroline Gauthier, 2012. "Which Model of Technology Transfer for Nanotechnology? A Comparison with Biotech and Microelectronics," Post-Print hal-00749152, HAL.
  40. Spelta, A. & Flori, A. & Pecora, N. & Pammolli, F., 2021. "Financial crises: Uncovering self-organized patterns and predicting stock markets instability," Journal of Business Research, Elsevier, vol. 129(C), pages 736-756.
  41. Martin Backfisch, 2018. "The Development of Firm Size and Innovativeness in the Pharmaceutical industry between 1989 and 2010," MAGKS Papers on Economics 201813, Philipps-Universität Marburg, Faculty of Business Administration and Economics, Department of Economics (Volkswirtschaftliche Abteilung).
  42. M'Chirgui, Zouhaïer, 2009. "Dynamics of R&D networked relationships and mergers and acquisitions in the smart card field," Research Policy, Elsevier, vol. 38(9), pages 1453-1467, November.
  43. repec:hal:spmain:info:hdl:2441/9933 is not listed on IDEAS
  44. McKelvey, Maureen & Alm, Hakan & Riccaboni, Massimo, 2003. "Does co-location matter for formal knowledge collaboration in the Swedish biotechnology-pharmaceutical sector?," Research Policy, Elsevier, vol. 32(3), pages 483-501, March.
  45. Fabio Pammolli & Massimo Riccaboni & Alessandro Spelta, 2021. "The network origins of Schumpeterian innovation," Journal of Evolutionary Economics, Springer, vol. 31(5), pages 1411-1431, November.
  46. Pierre-Alexandre Balland & Mathijs De Vaan & Ron Boschma, 2013. "The dynamics of interfirm networks along the industry life cycle: The case of the global video game industry, 1987--2007," Journal of Economic Geography, Oxford University Press, vol. 13(5), pages 741-765, September.
  47. BELDERBOS, René & GILSING, Victor & SUZUKI, Shinya, 2015. "Direct And Mediated Ties To Universities: ‘Scientific’ Absorptive Capacity And Innovation Performance Of Pharmaceutical Firms," Discussion paper series 2015-06, Hitotsubashi Institute for Advanced Study, Hitotsubashi University.
  48. Gilsing, V.A. & Nooteboom, B., 2004. "Co-evolution in innovation systems: the case of pharmaceutical biotechnology," Working Papers 04.09, Eindhoven Center for Innovation Studies.
  49. VAN DEN OORD, Ad & VAN WITTELOOSTUIJN, Arjen & DUYSTERS, Geert & GILSING, Victor, 2010. "The ecology of technology: An empirical study of US biotechnology patents from 1976 to 2003," ACED Working Papers 2010008, University of Antwerp, Faculty of Business and Economics.
  50. Maureen McKelvey, 2004. "Evolutionary Economics Perspectives on the Regional—National—International Dimensions of Biotechnology Innovations," Environment and Planning C, , vol. 22(2), pages 179-197, April.
  51. Jacqueline Senker, 2006. "Biotechnology Alliances in the European Pharmaceutical Industry: Past, Present and Future," SPRU Working Paper Series 137, SPRU - Science Policy Research Unit, University of Sussex Business School.
  52. repec:hal:wpspec:info:hdl:2441/9933 is not listed on IDEAS
  53. Herrmann, Andrea M., 2008. "Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry," MPIfG Discussion Paper 08/9, Max Planck Institute for the Study of Societies.
  54. Ron Boschma & Pierre-Alexandre Balland & Mathijs de Vaan, 2014. "The formation of economic networks: a proximity approach," Chapters, in: André Torre & Frédéric Wallet (ed.), Regional Development and Proximity Relations, chapter 7, pages 243-266, Edward Elgar Publishing.
  55. Lobo, José & Strumsky, Deborah, 2008. "Metropolitan patenting, inventor agglomeration and social networks: A tale of two effects," Journal of Urban Economics, Elsevier, vol. 63(3), pages 871-884, May.
  56. Hyunju Rachel Kim, 2014. "Formulation of a Success Model in Pharmaceutical R&D," SAGE Open, , vol. 4(1), pages 21582440145, March.
  57. Jing-Yuan Chio & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2012. "The Value of Failures in Pharmaceutical R&D," Working Papers 1/2012, IMT School for Advanced Studies Lucca, revised Jan 2012.
  58. Luca Verginer & Federica Parisi & Jeroen van Lidth de Jeude & Massimo Riccaboni, 2022. "The Impact of Acquisitions in the Biotechnology Sector on R&D Productivity," Papers 2203.12968, arXiv.org, revised Jan 2024.
  59. M. Laura Frigotto & Massimo Riccaboni, 2011. "A few special cases: scientific creativity and network dynamics in the field of rare diseases," Scientometrics, Springer;Akadémiai Kiadó, vol. 89(1), pages 397-420, October.
  60. M. C. Guardo & K. R. Harrigan, 2016. "Shaping the path to inventive activity: the role of past experience in R&D alliances," The Journal of Technology Transfer, Springer, vol. 41(2), pages 250-269, April.
  61. Jing Zhang & Charles Baden‐Fuller, 2010. "The Influence of Technological Knowledge Base and Organizational Structure on Technology Collaboration," Journal of Management Studies, Wiley Blackwell, vol. 47(4), pages 679-704, June.
  62. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2008. "Patent Value and R&D Competition," Working Papers 51/2008, University of Verona, Department of Economics.
  63. repec:spo:wpecon:info:hdl:2441/9933 is not listed on IDEAS
  64. Stefano Brusoni & Keith Pavitt, 2003. "Problem solving and the co-ordination of innovative activities," SPRU Working Paper Series 93, SPRU - Science Policy Research Unit, University of Sussex Business School.
  65. Bastian Rake & Pablo D’Este & Maureen McKelvey, 2021. "Exploring network dynamics in science: the formation of ties to knowledge translators in clinical research," Journal of Evolutionary Economics, Springer, vol. 31(5), pages 1433-1464, November.
  66. Jing-Yuan Chiou & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2016. "Learning from successes and failures in pharmaceutical R&D," Journal of Evolutionary Economics, Springer, vol. 26(2), pages 271-290, May.
  67. Johannes van Der Pol, 2015. "Structural dynamics of the French aerospace sector: A network analysis," Working Papers hal-01284993, HAL.
  68. João Amador & Sónia Cabral, 2017. "Networks of Value-added Trade," The World Economy, Wiley Blackwell, vol. 40(7), pages 1291-1313, July.
  69. Pinar Ozcan, 2018. "Growing with the market: How changing conditions during market growth affect formation and evolution of interfirm ties," Strategic Management Journal, Wiley Blackwell, vol. 39(2), pages 295-328, February.
  70. Jing Zhang & Charles Baden-Fuller & Vincent Mangematin, 2007. "Technological Knowledge Base, R&D Organization Structure and Alliance Formation: Evidence from the Biopharmaceutical Industry," Post-Print hal-00424512, HAL.
  71. Herrmann, Andrea M. & Peine, Alexander, 2011. "When 'national innovation system' meet 'varieties of capitalism' arguments on labour qualifications: On the skill types and scientific knowledge needed for radical and incremental product innovations," Research Policy, Elsevier, vol. 40(5), pages 687-701, June.
  72. Angelo Kenneth S. Romasanta & Peter Sijde & Jacqueline Muijlwijk-Koezen, 2020. "Innovation in pharmaceutical R&D: mapping the research landscape," Scientometrics, Springer;Akadémiai Kiadó, vol. 125(3), pages 1801-1832, December.
  73. Dantas, Eva & Bell, Martin, 2011. "The Co-Evolution of Firm-Centered Knowledge Networks and Capabilities in Late Industrializing Countries: The Case of Petrobras in the Offshore Oil Innovation System in Brazil," World Development, Elsevier, vol. 39(9), pages 1570-1591, September.
  74. Roijakkers, Nadine & Hagedoorn, John, 2006. "Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks," Research Policy, Elsevier, vol. 35(3), pages 431-446, April.
  75. Mariana Mazzucato & Massimiliano Tancioni, 2013. "R&D, Patents and Stock Return Volatility," Economic Complexity and Evolution, in: Andreas Pyka & Esben Sloth Andersen (ed.), Long Term Economic Development, edition 127, pages 341-362, Springer.
  76. Ad van den Oord & Arjen van Witteloostuijn, 2018. "A multi-level model of emerging technology: An empirical study of the evolution of biotechnology from 1976 to 2003," PLOS ONE, Public Library of Science, vol. 13(5), pages 1-27, May.
  77. Gilsing, Victor & Nooteboom, Bart, 2006. "Exploration and exploitation in innovation systems: The case of pharmaceutical biotechnology," Research Policy, Elsevier, vol. 35(1), pages 1-23, February.
  78. Pammolli, Fabio & Riccaboni, Massimo, 2004. "Market Structure and Drug Innovation," MPRA Paper 16212, University Library of Munich, Germany.
  79. Katarina Larsen, 2008. "Knowledge network hubs and measures of research impact, science structure, and publication output in nanostructured solar cell research," Scientometrics, Springer;Akadémiai Kiadó, vol. 74(1), pages 123-142, January.
  80. Bonaccorsi, Andrea & Giuri, Paola, 2001. "The long-term evolution of vertically-related industries," International Journal of Industrial Organization, Elsevier, vol. 19(7), pages 1053-1083, July.
  81. Ad van den Oord & Arjen van Witteloostuijn, 2017. "The Population Ecology of Technology: An Empirical Study of US Biotechnology Patents from 1976 to 2003," PLOS ONE, Public Library of Science, vol. 12(1), pages 1-26, January.
  82. Bruce Rasmussen, 2010. "Innovation and Commercialisation in the Biopharmaceutical Industry," Books, Edward Elgar Publishing, number 13680.
  83. Fabius Abrahão Torreão Esteves & Claude Pirmez & Manuela da Silva & Carla Torreão Esteves & Andréa Torreão Esteves & Roberto Pierre Chagnon & Elton Fernandes, 2016. "Social Network Analysis as an Analytical Archetype of R&D National Networks: Case Study in Culture Collections of Brazil and Japan," Review of Social Sciences, LAR Center Press, vol. 1(5), pages 1-17, May.
  84. Andrea Bonaccorsi & Paola Giuri, 2001. "Learning, technological competition and network structure in the aero-engine industry," LEM Papers Series 2001/11, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  85. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2009. "Nuove politiche per l'innovazione nel settore delle scienze della vita," Working Papers CERM 03-2009, Competitività, Regole, Mercati (CERM).
  86. Ronnie Ramlogan & Davide Consoli, 2014. "Dynamics of collaborative research medicine: the case of glaucoma," The Journal of Technology Transfer, Springer, vol. 39(4), pages 544-566, August.
  87. Patrick Wolf & Tobias Buchmann, 2021. "Analyzing development patterns in research networks and technology," Review of Evolutionary Political Economy, Springer, vol. 2(1), pages 55-81, April.
  88. Vermeulen, Ben & De Kok, Ton, 2013. "A value network development model and implications for innovation and production network management," MPRA Paper 51393, University Library of Munich, Germany.
  89. Muhamed Kudic & Matthias Müller & Tobias Buchmann & Andreas Pyka & Jutta Günther, 2021. "Network dynamics, economic transition, and policy design—an introduction," Review of Evolutionary Political Economy, Springer, vol. 2(1), pages 1-8, April.
  90. Kitsak, Maksim & Havlin, Shlomo & Paul, Gerald & Riccaboni, Massimo & Pammolli, Fabio & Stanley, H. Eugene, 2007. "Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks," MPRA Paper 15907, University Library of Munich, Germany.
  91. repec:hal:spmain:info:hdl:2441/7346 is not listed on IDEAS
  92. Könnölä, Totti & Eloranta, Ville & Turunen, Taija & Salo, Ahti, 2021. "Transformative governance of innovation ecosystems," Technological Forecasting and Social Change, Elsevier, vol. 173(C).
  93. Riccaboni, Massimo & Pammolli, Fabio, 2002. "On firm growth in networks," Research Policy, Elsevier, vol. 31(8-9), pages 1405-1416, December.
  94. Cowan, Robin, 2004. "Network models of innovation and knowledge diffusion," Research Memorandum 016, Maastricht University, Maastricht Economic Research Institute on Innovation and Technology (MERIT).
  95. Kimmo Viljamaa, 2003. "The technological, economic and institutional aspects behind the development of biotechnology industry in Turku region, Finland," ERSA conference papers ersa03p282, European Regional Science Association.
  96. Wield, David & Tait, Joyce & Chataway, Joanna & Mittra, James & Mastroeni, Michele, 2017. "Conceptualising and practising multiple knowledge interactions in the life sciences," Technological Forecasting and Social Change, Elsevier, vol. 116(C), pages 308-315.
  97. Alexandre Trigo, 2016. "Innovation in the Era of Experience: The Changing Role of Users in Healthcare Innovation," Journal of Entrepreneurship, Management and Innovation, Fundacja Upowszechniająca Wiedzę i Naukę "Cognitione", vol. 12(2), pages 29-51.
  98. Jackie Krafft & Francesco Quatraro, 2011. "The dynamics of technological knowledge," Post-Print halshs-00727633, HAL.
  99. Gunno Park & Jina Kang, 2014. "Effect of Alliance Experience on New Alliance Formations and Internal R&D Capabilities," TEMEP Discussion Papers 2014119, Seoul National University; Technology Management, Economics, and Policy Program (TEMEP), revised Sep 2014.
  100. Sun, Yutao, 2016. "The structure and dynamics of intra- and inter-regional research collaborative networks: The case of China (1985–2008)," Technological Forecasting and Social Change, Elsevier, vol. 108(C), pages 70-82.
  101. Alena Zemplinerova, 2010. "Competition policy and economic analysis: What can we learn from firm and industry data?," CERGE-EI Books, The Center for Economic Research and Graduate Education - Economics Institute, Prague, edition 1, number b07, May.
  102. Philip Cooke, 2010. "Global Bioregions: Knowledge Domains, Capabilities and Innovation System Networks," Chapters, in: Riccardo Viale & Henry Etzkowitz (ed.), The Capitalization of Knowledge, chapter 5, Edward Elgar Publishing.
  103. Bettencourt, Luis M.A. & Lobo, Jose & Strumsky, Deborah, 2007. "Invention in the city: Increasing returns to patenting as a scaling function of metropolitan size," Research Policy, Elsevier, vol. 36(1), pages 107-120, February.
  104. Franco Malerba, 2006. "Innovation and the evolution of industries," Journal of Evolutionary Economics, Springer, vol. 16(1), pages 3-23, April.
  105. Claudimar Pereira da Veiga & Cassia Rita Pereira da Veiga & Mônica Maier Giacomini & Heitor Takashi Kato & Jansen Maia Del Corso, 2015. "Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market," International Review of Management and Marketing, Econjournals, vol. 5(3), pages 141-153.
  106. Yutao Sun & Kai Liu, 2016. "Proximity effect, preferential attachment and path dependence in inter-regional network: a case of China’s technology transaction," Scientometrics, Springer;Akadémiai Kiadó, vol. 108(1), pages 201-220, July.
  107. Cowan, Robin & Jonard, Nicolas & Özman, Müge, 2003. "Knowledge Dynamics in a Network Industry," Research Memorandum 003, Maastricht University, Maastricht Economic Research Institute on Innovation and Technology (MERIT).
  108. Huatao Peng & Geert Duysters & Bert Sadowski, 2016. "The changing role of guanxi in influencing the development of entrepreneurial companies: a case study of the emergence of pharmaceutical companies in China," International Entrepreneurship and Management Journal, Springer, vol. 12(1), pages 215-258, March.
  109. Margarida Fontes, 2005. "Distant networking: The knowledge acquisition strategies of 'out-cluster' biotechnology firms," European Planning Studies, Taylor & Francis Journals, vol. 13(6), pages 899-920, September.
  110. Mahlich, Jörg C. & Roediger-Schluga, Thomas, 2001. "The Changing Nature of Pharmaceutical R&D - Opportunities for Asia?," Research Memorandum 001, Maastricht University, Maastricht Economic Research Institute on Innovation and Technology (MERIT).
  111. Gay, Brigitte & Dousset, Bernard, 2005. "Innovation and network structural dynamics: Study of the alliance network of a major sector of the biotechnology industry," Research Policy, Elsevier, vol. 34(10), pages 1457-1475, December.
  112. Moritz Müller & Robin COWAN & Geert Duysters & Nicolas JONARD, 2009. "Knowledge Structures," Working Papers of BETA 2009-24, Bureau d'Economie Théorique et Appliquée, UDS, Strasbourg.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.